Case report: Clinical course and treatment of SARS-CoV-2 in a pediatric CAR-T cell recipient with persistent hypogammaglobulinemia
This report describes a pediatric patient who underwent chimeric antigen receptor (CAR) T-cell therapy for refractory B-cell acute lymphoblastic leukemia (B-ALL) four years prior, with resultant hypogammaglobulinemia for which he was receiving weekly subcutaneous immune globulin. He presented with p...
Saved in:
Main Authors: | Howard Sanders (Author), Christina Callas (Author), Helaine St. Amant (Author), Jong Chung (Author), Victoria R. Dimitriades (Author), Natasha A. Nakra (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy
by: Katherine Cotangco, et al.
Published: (2022) -
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
by: Amer M. Khojah, et al.
Published: (2019) -
Strategies to enhance CAR-T persistence
by: Yue Liu, et al.
Published: (2022) -
Hypogammaglobulinemia and periodic fevers - Think of TRNT1 deficiency!
by: Rilna Joseph, et al.
Published: (2021) -
Rituximab and hypogammaglobulinemia in the setting of ABO-incompatible kidney transplantation
by: Hamza Naciri Bennani, et al.
Published: (2018)